We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is CCEP Worth Buying as Growth Improves but Valuation Stays Rich?
Read MoreHide Full Article
Key Takeaways
CCEP's first-half revenues rose 6.1%, while operating profit climbed 8.1%, supported by productivity gains.
CCEP targets Euro 1.7 billion in 2026 free cash flow, supporting investments in capacity and distribution.
CCEP trades at 21.3X forward P/E, above its five-year median of 16.7X, raising entry risks amid higher costs.
Coca-Cola Europacific Partners plc (CCEP - Free Report) combines improving operating growth with a valuation that already sits near the top of its historical range. Faster-growing beverage categories, better productivity and healthy cash generation support the business case.
The trade-off is price. Consumer affordability remains a concern, revenue per unit case is advancing only modestly and higher cost inflation is expected in the second half of 2026. That mix favors selectivity rather than chasing growth at any valuation.
CCEP’s Growth Portfolio Strengthens the Bull Case
CCEP is broadening beyond traditional sparkling drinks into zero sugar, energy, sports and hydration. In the first half of 2026, sports volumes rose 12%, energy increased 19% and zero-sugar volumes advanced about 10%. Product launches and new pack formats can widen consumption occasions and help recruit consumers.
Energy remains a particularly active category. Monster Beverage Corporation (MNST - Free Report) , whose brands are distributed by CCEP in several markets, reported a 21.6% increase in second-quarter 2026 net sales for its Monster Energy Drinks segment. That backdrop supports CCEP’s push into faster-growing beverage categories.
CCEP’s Profit Growth Outpaces Revenue
Comparable FX-neutral revenues increased 6.1% in the first half of 2026, while comparable operating profit rose 8.1%. Operating margin reached 13.8%, up about 30 basis points, as productivity, efficiency programs and tighter discretionary spending helped profits grow faster than revenues.
Keurig Dr Pepper Inc. (KDP - Free Report) provides another beverage-industry example of growth supported by operating leverage. Its U.S. Refreshment Beverages net sales increased 10% in the second quarter of 2026, driven by 6.5% volume and mix growth and 3.5% net price realization.
Coca-Cola Europacific Partners Price and Consensus
Comparable free cash flow reached €435 million in the first half despite investment in coolers, production lines, technology and the new Manila facility. The company remains on track for at least €1.7 billion of comparable free cash flow for 2026.
That cash generation gives CCEP room to invest in capacity and distribution while maintaining its broader growth program. More than 80,000 coolers were added during the first half, and the Philippines facility remains scheduled to begin production in 2027, supporting future demand.
CCEP’s Premium Multiple Raises the Entry Risk
Valuation is the main counterweight to the improving operating picture. CCEP trades at 21.3X forward 12-month earnings, above the soft-drink sub-industry’s 20.1X and well above its own five-year median of 16.7X. The multiple is also close to its five-year high of 21.5X.
That premium leaves less room for execution setbacks. Revenue per unit case rose just 0.4% in the first half, while cost of sales per unit case is expected to increase about 1.5% for 2026. Affordability pressure could also limit CCEP’s ability to rely on pricing and mix to offset inflation.
Image Source: Zacks Investment Research
CCEP’s Ratings Favor Patience Over Chasing Growth
CCEP’s fundamentals are improving, but the combination of a premium valuation and near-term estimate pressure argues against treating the growth story alone as a sufficient reason to buy at current levels. The business has multiple growth levers, yet the present valuation demands continued execution.
The stock currently carries a Zacks Rank #4 (Sell). CCEP has a Growth Score of B, but its Value Score of D, Momentum Score of C and VGM Score of C are less supportive. Because Zacks Style Scores are designed to complement the Zacks Rank, the current mix favors patience over a fresh entry despite the company’s improving operating profile.
View the Zacks #1 Rank List
Image: Bigstock
Is CCEP Worth Buying as Growth Improves but Valuation Stays Rich?
Key Takeaways
Coca-Cola Europacific Partners plc (CCEP - Free Report) combines improving operating growth with a valuation that already sits near the top of its historical range. Faster-growing beverage categories, better productivity and healthy cash generation support the business case.
The trade-off is price. Consumer affordability remains a concern, revenue per unit case is advancing only modestly and higher cost inflation is expected in the second half of 2026. That mix favors selectivity rather than chasing growth at any valuation.
CCEP’s Growth Portfolio Strengthens the Bull Case
CCEP is broadening beyond traditional sparkling drinks into zero sugar, energy, sports and hydration. In the first half of 2026, sports volumes rose 12%, energy increased 19% and zero-sugar volumes advanced about 10%. Product launches and new pack formats can widen consumption occasions and help recruit consumers.
Energy remains a particularly active category. Monster Beverage Corporation (MNST - Free Report) , whose brands are distributed by CCEP in several markets, reported a 21.6% increase in second-quarter 2026 net sales for its Monster Energy Drinks segment. That backdrop supports CCEP’s push into faster-growing beverage categories.
CCEP’s Profit Growth Outpaces Revenue
Comparable FX-neutral revenues increased 6.1% in the first half of 2026, while comparable operating profit rose 8.1%. Operating margin reached 13.8%, up about 30 basis points, as productivity, efficiency programs and tighter discretionary spending helped profits grow faster than revenues.
Keurig Dr Pepper Inc. (KDP - Free Report) provides another beverage-industry example of growth supported by operating leverage. Its U.S. Refreshment Beverages net sales increased 10% in the second quarter of 2026, driven by 6.5% volume and mix growth and 3.5% net price realization.
Coca-Cola Europacific Partners Price and Consensus
Coca-Cola Europacific Partners price-consensus-chart | Coca-Cola Europacific Partners Quote
CCEP’s Cash Flow Funds Continued Investment
Comparable free cash flow reached €435 million in the first half despite investment in coolers, production lines, technology and the new Manila facility. The company remains on track for at least €1.7 billion of comparable free cash flow for 2026.
That cash generation gives CCEP room to invest in capacity and distribution while maintaining its broader growth program. More than 80,000 coolers were added during the first half, and the Philippines facility remains scheduled to begin production in 2027, supporting future demand.
CCEP’s Premium Multiple Raises the Entry Risk
Valuation is the main counterweight to the improving operating picture. CCEP trades at 21.3X forward 12-month earnings, above the soft-drink sub-industry’s 20.1X and well above its own five-year median of 16.7X. The multiple is also close to its five-year high of 21.5X.
That premium leaves less room for execution setbacks. Revenue per unit case rose just 0.4% in the first half, while cost of sales per unit case is expected to increase about 1.5% for 2026. Affordability pressure could also limit CCEP’s ability to rely on pricing and mix to offset inflation.
Image Source: Zacks Investment Research
CCEP’s Ratings Favor Patience Over Chasing Growth
CCEP’s fundamentals are improving, but the combination of a premium valuation and near-term estimate pressure argues against treating the growth story alone as a sufficient reason to buy at current levels. The business has multiple growth levers, yet the present valuation demands continued execution.
The stock currently carries a Zacks Rank #4 (Sell). CCEP has a Growth Score of B, but its Value Score of D, Momentum Score of C and VGM Score of C are less supportive. Because Zacks Style Scores are designed to complement the Zacks Rank, the current mix favors patience over a fresh entry despite the company’s improving operating profile.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.